Microfluidic Chip Takes Blood Cells Through a Labyrinth to Pick Out CTCs

Picking out circulating tumor cells (CTCs) from whole blood, known as liquid biopsy, should soon be a regular way to screen for cancer and to monitor patients that have undergone treatment. There is also evidence that there are so-called cancer stem cells (CSCs) that are particularly aggressive and that are able to morph into any kind of cell foun (Read more...)

Full Story →